Leptin

Generic Name
Leptin
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
-
CAS Number
169494-85-3
Unique Ingredient Identifier
Q09SXY6BFI
Background

Although leptin is a circulating signal that reduces appetite, in general, obese people have an unusually high circulating concentration of leptin. These people are said to be resistant to the effects of leptin, in much the same way that people with type 2 diabetes are resistant to the effects of insulin. Thus, obesity develops when people take in more energy than they use over a prolonged period of time, and this excess food intake is not driven by hunger signals, occurring in spite of the anti-appetite signals from circulating leptin. The high sustained concentrations of leptin from the enlarged fat stores result in the cells that respond to leptin becoming desensitized.

Indication

Investigated for use/treatment in lipodystrophy and obesity.

Associated Conditions
-
Associated Therapies
-

Effects of Leptin Treatment on Weight Loss

Phase 2
Completed
Conditions
Interventions
First Posted Date
2002-12-23
Last Posted Date
2010-10-19
Lead Sponsor
Rockefeller University
Target Recruit Count
40
Registration Number
NCT00050791
Locations
🇺🇸

Rockefeller University Hospital, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath